A bone researcher based in Japan with 10 retractions under his belt has retracted two more papers for similar reasons — problems with the underlying data, and including co-authors who didn’t participate in the project.
In both notices, Yoshihiro Sato is pegged as responsible for the content of the papers. The newly retracted research covers a long timespan — one paper was published in 2000, the other in 2013.
Sometimes, the best way to expose a problem with the publishing process is to put it to a test — perhaps by performing a Sokal-style hoax, or submitting a paper with obvious flaws.
In 2014, that’s just what a researcher in Kosovo did. Suspicious that a journal wasn’t doing a thorough job of vetting submissions, she decided to send them an article of hers that had already appeared in another journal. Her thinking was that any journal with an honest and thorough peer review process would hesitate to publish the work. But this journal didn’t — at least at first. Though they retracted the paper this summer, it took a few twists and turns to get there.
The latest retraction stemmed from a re-analysis of the paper by the Canadian Multicentre Osteoporosis Study Group, of which the paper was a part; all authors but Jamal have requested the retraction. In the notice, the authors say that they believe no patients were harmed as a result of the “possibly invalid conclusions” in the paper, which showed patients with kidney problems were at higher risk of bone loss. A researcher told us a third paper by Jamal is also due to be retracted soon.
A researcher is calling for the retraction of a paper about a recent ban in the use of organs from executed prisoners in China, accusing the authors of misrepresenting the state of the practice.
In April 2015, a paper in the Journal of Medical Ethics welcomed the ban by the Chinese government as “a step in the right direction,” but noted that China remains plagued by a crucial shortage in available organs.
Some academics disagreed with the authors’ take on the issue, noting that the paper fails to note that many organs may continue to be harvested from Chinese prisoners of conscience; ultimately, the journal received a letter asking to retract the paper. The journal decided not to, and instead asked the authors to issue a lengthy correction, for instance changing the language about the government decision (“law” became“guideline”), and allowed critics to publish a rebuttal to the paper in May 2016. Continue reading Is China using organs from executed prisoners? Researchers debate issue in the literature
A biomaterials researcher has lost four more papers for figure-related issues such as duplications, bringing his total to seven retractions.
We previously reported on three retractions — two by the Journal of Controlled Release (JCR) — of papers co-authored by Hossein Hosseinkhani, who is currently based at the National Taiwan University of Science and Technology in Taipei. Now, the JCR is pulling four more studies that list Hosseinkhani as a co-author.
falsified and/or fabricated quantitative real-time polymerase chain reaction (qPCR) data to demonstrate a statistically significant or “trend” of statistical difference in the expression of renal or bladder urothelium and muscle developmental markers between control and experimental (mutant) mice, when there was none.
The ORI report said that Walker has agreed to retract or correct a 2013 PLOS ONE paper and a 2015 study published in American Journal of Physiology – Renal Physiology (AJPRP).
A team of researchers has earned its third retraction after an investigation at Oita University in Japan found instances of misconduct in their research.
The most recent notice mentions the investigation, and specifies that the first author, Satoshi Hagiwara, was responsible for the problematic figures in the paper. Hagiwara is also the first author on two retracted papers we reported on last year; one of the earlier retractions also mentions the investigation, but does not assign responsibility to any particular author. All three papers share three authors.
The corresponding author asked the Journal of Pediatric Orthopaedics to retract an article that found popular pain medicines can curb growth in rats, in light of an unresolved authorship dispute.
The article, “Nonsteroidal Anti-Inflammatory Drugs Cause Inhibition of the Growth Plate in Cultured Rat Metatarsal Bones,” details preliminary results that indicate nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce growth in rat bones in a dose-dependent manner, suggesting caution in treating chronic inflammatory diseases in children. The editor told us the paper was “highly rated” by reviewers and the results were “never in question,” but the senior author asked to pull the paper after failing to resolve a dispute with a researcher who asked to be added as an author.